X-13319370-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001135995.2(ATXN3L):c.565C>T(p.Pro189Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000199 in 1,208,873 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001135995.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN3L | NM_001135995.2 | c.565C>T | p.Pro189Ser | missense_variant | 1/1 | ENST00000380622.5 | NP_001129467.1 | |
ATXN3L | NM_001387036.1 | c.301C>T | p.Pro101Ser | missense_variant | 2/2 | NP_001373965.1 | ||
GS1-600G8.3 | NR_046087.1 | n.1811G>A | non_coding_transcript_exon_variant | 16/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATXN3L | ENST00000380622.5 | c.565C>T | p.Pro189Ser | missense_variant | 1/1 | 6 | NM_001135995.2 | ENSP00000369996.2 | ||
GS1-600G8.3 | ENST00000431486.1 | n.1811G>A | non_coding_transcript_exon_variant | 16/17 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111284Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33544
GnomAD3 exomes AF: 0.0000387 AC: 7AN: 180937Hom.: 0 AF XY: 0.0000448 AC XY: 3AN XY: 66981
GnomAD4 exome AF: 0.0000200 AC: 22AN: 1097589Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 8AN XY: 363021
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111284Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33544
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2022 | The c.565C>T (p.P189S) alteration is located in exon 1 (coding exon 1) of the ATXN3L gene. This alteration results from a C to T substitution at nucleotide position 565, causing the proline (P) at amino acid position 189 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at